Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

SANDOSTATIN

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is SANDOSTATIN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that SANDOSTATIN 100MCG has been permanently discontinued (last updated March 22, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is SANDOSTATIN not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength100MCG
Last updated2024-03-22

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

OCTREOTIDE ACETATE INJECTION - 100MCG/ML

SANDOZ CANADA INCORPORATED

100MCG · DIN 02263173

Same strengthSame dosage formSame routeNo current shortage

OCTREOTIDE ACETATE INJECTION

GENERIC MEDICAL PARTNERS INC

100MCG · DIN 02509768

Same strengthSame dosage formSame routeNo current shortage

Other Products

SANDOSTATIN

NOVARTIS PHARMACEUTICALS CANADA INC

500MCG · DIN 00839213

Different strengthSame dosage formSame routeNo current shortage

OCTREOTIDE ACETATE INJECTION - 500MCG/ML

SANDOZ CANADA INCORPORATED

500MCG · DIN 02263203

Different strengthSame dosage formSame routeNo current shortage

OCTREOTIDE ACETATE INJECTION - 50MCG/ML

SANDOZ CANADA INCORPORATED

50MCG · DIN 02263165

Different strengthSame dosage formSame routeNo current shortage

OCTREOTIDE INJECTION

TEVA CANADA LIMITED

200MCG · DIN 02299445

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00839205

Strength

100MCG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS

Active Ingredient

OCTREOTIDE

See all OCTREOTIDE products →

Shortage History